{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:32Z","timestamp":1791397352350,"version":"4.3.3"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2011]]},"DOI":"10.2169\/internalmedicine.50.4483","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T06:41:29Z","timestamp":1316068889000},"page":"1973-1976","source":"Crossref","is-referenced-by-count":11,"title":["Propylthiouracil-induced Anti-neutrophil Cytoplasmic Antibodies and Agranulocytosis together with Granulocyte Colony-stimulating Factor Induced Sweet's Syndrome in a Patient with Graves' Disease"],"prefix":"10.2169","volume":"50","author":[{"given":"Celik","family":"Ozlem","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, University of Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyuktas","family":"Deram","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, University of Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevinc","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, University of Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tascilar","family":"Koray","sequence":"additional","affiliation":[{"name":"Division of Romatology, Department of Internal Medicine, Cerrahpasa Medical School, University of Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demirkesen","family":"Cuyan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cerrahpasa Medical School, University of Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasan","family":"Ertugrul","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, University of Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14: 33-41, 2009.","DOI":"10.1111\/j.1440-1797.2009.01100.x"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342: 651-652, 1993.","DOI":"10.1016\/0140-6736(93)91761-A"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil. Int J Clin Pract 63: 299-302, 2009.","DOI":"10.1111\/j.1742-1241.2006.01250.x"},{"key":"4","unstructured":"4. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 3: 117-131, 2002."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kim MJ, Choe YH. EPONYM: Sweet syndrome. Eur J Pediatr 169: 1439-1444, 2010.","DOI":"10.1007\/s00431-010-1201-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Boulenger-Vazel A, Kupfer-Bessaguet I, Gouedard C, et al. Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies). Ann Dermatol Venereol 132: 27-31, 2005.","DOI":"10.1016\/S0151-9638(05)79191-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Seo JW, Son HH, Choi JH, Lee SK. A case of p-ANCA-positive propylthiouracil-induced pyoderma gangrenosum. Ann Dermatol 22: 48-50, 2010.","DOI":"10.5021\/ad.2010.22.1.48"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 130: 77-81, 1994.","DOI":"10.1001\/archderm.1994.01690010081012"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. White LE, Villa MT, Petronic-Rosic V, Jiang J, Medenica MM. Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. Skinmed 5: 96-98, 2006.","DOI":"10.1111\/j.1540-9740.2006.04575.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Noh JY, Yasuda S, Sato S, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab 94: 2806-2811, 2009.","DOI":"10.1210\/jc.2008-2700"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miller RM, Darben TA, Nedwich J, Savige J. Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis. Br J Dermatol 141: 943-944, 1999.","DOI":"10.1046\/j.1365-2133.1999.03186.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kemmett D, Harrison DJ, Hunter JA. Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol 24: 967-969, 1991.","DOI":"10.1016\/0190-9622(91)70154-T"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 3: 117-131, 2002.","DOI":"10.2165\/00128071-200203020-00005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, M&uuml;ller CA, Waller HD. Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol 84: 356-358, 1993.","DOI":"10.1111\/j.1365-2141.1993.tb03083.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Otsuka S, Kinebuchi A, Tabata H, Yamakage A, Yamazaki S. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy. Br J Dermatol 142: 828-830, 2000.","DOI":"10.1046\/j.1365-2133.2000.03445.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/50\/18\/50_18_1973\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T02:20:46Z","timestamp":1497925246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/50\/18\/50_18_1973\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":15,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.50.4483","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}